To test a causal role of bone-marrow-derived MPO in CKD-accelerated atherosclerosis, we created a mouse model of CKD on the LDLr−/− background with bone marrow cell–specific modulation of MPO expression. The gene discussed is MPO; the disease is chronic kidney disease.